| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Milestone Pharmaceuticals Inc. | 3,354,825 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-14 | Venrock Healthcare Capital Partners III, L.P. | Milestone Pharmaceuticals Inc. | 925,048 | 2.8% | EDGAR |
| SC 13G/A | 2024-02-09 | GOLDMAN SACHS GROUP INC | Milestone Pharmaceuticals Inc. | 1,359,540 | 4.1% | EDGAR |
| SC 13G/A | 2024-01-29 | INTEGRATED CORE STRATEGIES (US) LLC | Milestone Pharmaceuticals Inc. | 1,727,245 | 5.2% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | Milestone Pharmaceuticals Inc. | 3,270,749 | 9.8% | EDGAR |
| SC 13D | 2023-11-09 | Alta Fundamental Advisers LLC | Milestone Pharmaceuticals Inc. | 1,671,289 | 5.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Boxer Capital, LLC | Milestone Pharmaceuticals Inc. | 698,861 | 2.0% | EDGAR |
| SC 13G/A | 2023-02-14 | ORBIMED CAPITAL LLC | Milestone Pharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Venrock Healthcare Capital Partners III, L.P. | Milestone Pharmaceuticals Inc. | 2,208,812 | 6.4% | EDGAR |
| SC 13G/A | 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. | Milestone Pharmaceuticals Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Ikarian Capital, LLC | Milestone Pharmaceuticals Inc. | 460,416 | 1.3% | EDGAR |
| SC 13G/A | 2023-02-13 | BlackRock Inc. | Milestone Pharmaceuticals Inc. | 1,727,829 | 5.0% | EDGAR |
| SC 13G | 2023-01-19 | GOLDMAN SACHS GROUP INC | Milestone Pharmaceuticals Inc. | 2,750,385 | 8.0% | EDGAR |
| SC 13G/A | 2023-01-18 | INTEGRATED CORE STRATEGIES (US) LLC | Milestone Pharmaceuticals Inc. | 1,893,337 | 5.5% | EDGAR |
| SC 13G | 2022-10-31 | INTEGRATED CORE STRATEGIES (US) LLC | Milestone Pharmaceuticals Inc. | 1,604,742 | 5.3% | EDGAR |
| SC 13D/A | 2022-10-24 | Novo Holdings A/S | Milestone Pharmaceuticals Inc. | 1,378,538 | 4.6% | EDGAR |
| SC 13D/A | 2022-09-26 | Novo Holdings A/S | Milestone Pharmaceuticals Inc. | 2,097,713 | 7.0% | EDGAR |
| SC 13G | 2022-09-20 | Venrock Healthcare Capital Partners III, L.P. | Milestone Pharmaceuticals Inc. | 2,072,009 | 6.9% | EDGAR |
| SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | Milestone Pharmaceuticals Inc. | 4,315,102 | 14.4% | EDGAR |
| SC 13G/A | 2022-02-14 | RA CAPITAL MANAGEMENT, L.P. | Milestone Pharmaceuticals Inc. | 2,246,503 | 7.5% | EDGAR |